Robotic vs Standard Keyhole Surgery for Early-Stage Lung Cancer: An Australian Randomised Controlled Trial (RAVAL)
Not Applicable
- Conditions
- Lung Cancerung CancerCancer - Lung - Non small cell
- Registration Number
- ACTRN12624000951550
- Lead Sponsor
- St Vincent's Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
•Age 18 years and above
•Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
•Candidates for minimally invasive pulmonary surgery, as determined by the operating surgeon.
Exclusion Criteria
•Not a candidate for minimally invasive lobectomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The trial is intended to determine the difference in participant-reported HRQOL outcomes between RTS-Lobectomy and VATS-Lobectomy at 12 weeks. [Health related Quality of Life (HRQOL). 12 weeks post surgery.]
- Secondary Outcome Measures
Name Time Method